Home›Companies›Healthcare›Aperon

Aperon, Inc.

Aperon builds documentation software for clinical trial sponsors.

Updated Nov 9, 2026·Latest SEC filing Aug 4, 2026·Suggest an edit

About Aperon

Aperon is a private company based in Cambridge, Massachusetts, incorporated in 2026 in Delaware. It has reported $505,000 raised in one offering on Form D since August 2026. Its chief executive is Joshua Moscato.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 5, 2026Aug 4, 2026$505,000target not set7$72,143Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aperon's Form D filed Aug 4, 2026.

JM
Joshua Moscato
Founder & CEO, director

Sources

  1. SECAperon, Inc. filing history